Potential Inhibition of COVID-19-driven Pneumonia by Immunosuppressive Therapy and anti-TNF&#945; Antibodies: A Case Report.

Kunisaki, Reiko; Tsukiji, Jun; Kudo, Makoto

Potential Inhibition of COVID-19-driven Pneumonia by Immunosuppressive Therapy and anti-TNFα Antibodies: A Case Report.

Kunisaki, Reiko; Tsukiji, Jun; Kudo, Makoto.

Kunisaki R; Inflammatory Bowel Disease Centre, Yokohama City University Medical Centre, Yokohama, Japan.
Tsukiji J; Department of Infection Prevention and Control, Yokohama City University Medical Centre, Yokohama, Japan.
Kudo M; Respiratory Disease Centre, Yokohama City University Medical Centre, Yokohama, Japan.

J Crohns Colitis ; 14(12): 1786-1787, 2020 Dec 02.

Article in English | MEDLINE | ID: covidwho-436582

Subject(s)

COVID-19/immunology; Colitis, Ulcerative/drug therapy; Immunosuppressive Agents/therapeutic use; Infliximab/therapeutic use; Tumor Necrosis Factor-alpha/immunology; COVID-19/complications; COVID-19/physiopathology; COVID-19/prevention & control; Colitis, Ulcerative/complications; Colitis, Ulcerative/immunology; Humans; Male; Middle Aged; Patient Acuity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Colitis, Ulcerative / Tumor Necrosis Factor-alpha / Infliximab / COVID-19 / Immunosuppressive Agents Type of study: Case report / Observational study / Prognostic study Topics: Long Covid Limits: Humans / Male / Middle aged Language: English Journal: J Crohns Colitis Journal subject: Gastroenterology Year: 2020 Document Type: Article Affiliation country: Ecco-jcc

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google